Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Identifying the role of protein isomers in the B-cell lymphoma 2 (BCL-2) protein family in inducing the anti-apoptotic phenotype in ovarian cancer cells

FY 2020-21

Summary
Among all gynecological cancers, ovarian cancer is associated with the worst prognosis and highest mortality rate. A hallmark feature of cancer cells is their ability to avoid apoptosis, a mechanism of programmed cell death. Understanding the proteins that carry out cellular apoptosis will provide key insights into potential targets for inhibiting the anti-apoptotic characteristic of cancer cells. The B-cell lymphoma 2 (BCL-2) family of proteins are key regulators of the apoptotic pathway and consequently are altered in various cancers. However, there are many variants, or isoforms, of a given protein in the BCL-2 family. The specific role of each protein isoform in the context of apoptosis is yet to be elucidated. Here, we aim to study the expression and function of protein isoforms in the BCL-2 family and their role in regulating apoptosis in healthy and cancerous ovarian cells. First, we aim to quantify the amount of each BCL-2 family protein isoform in healthy and cancerous ovarian cells. Next, we will alter the expression of specific BCL-2 family protein isoforms and assess the susceptibility of these cells to pharmacologically-induced apoptosis. By the end of this project, we hope to determine a potential list of isoform-specific BCL-2 protein targets for developing therapeutics against ovarian cancer.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449661
Name
Nath Niloy C
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying the role of protein isomers in the B-cell lymphoma 2 (BCL-2) protein family in inducing the anti-apoptotic phenotype in ovarian cancer cells
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apoptosis; B-Cell Lymphoma 2 Protein Family; Cancer; Ovarian Cancer
Abstract
Among all gynecological cancers, ovarian cancer is associated with the worst prognosis and highest mortality rate. A hallmark feature of cancer cells is their ability to avoid apoptosis, a mechanism of programmed cell death. Understanding the proteins that carry out cellular apoptosis will provide key insights into potential targets for inhibiting the anti-apoptotic characteristic of cancer cells. The B-cell lymphoma 2 (BCL-2) family of proteins are key regulators of the apoptotic pathway and consequently are altered in various cancers. However, there are many variants, or isoforms, of a given protein in the BCL-2 family. The specific role of each protein isoform in the context of apoptosis is yet to be elucidated. Here, we aim to study the expression and function of protein isoforms in the BCL-2 family and their role in regulating apoptosis in healthy and cancerous ovarian cells. First, we aim to quantify the amount of each BCL-2 family protein isoform in healthy and cancerous ovarian cells. Next, we will alter the expression of specific BCL-2 family protein isoforms and assess the susceptibility of these cells to pharmacologically-induced apoptosis. By the end of this project, we hope to determine a potential list of isoform-specific BCL-2 protein targets for developing therapeutics against ovarian cancer.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nath, Niloy C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~